Provided by Tiger Fintech (Singapore) Pte. Ltd.

Petros Pharmaceuticals Inc

0.0730
-0.0049-6.29%
Post-market: 0.0729-0.0001-0.14%17:07 EDT
Volume:5.33M
Turnover:382.45K
Market Cap:1.84M
PE:-0.02
High:0.0762
Open:0.0750
Low:0.0680
Close:0.0779
Loading ...

Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study

ACCESS Newswire
·
25 Feb

Petros Pharmaceuticals Prices $9.6 Million Public Offering of Shares, Warrants

MT Newswires Live
·
18 Feb

US Stocks Mixed; NY State Business Activity Rises In February

Benzinga
·
18 Feb

Petros Pharmaceuticals prices 40M shares at 24c in public offering

TIPRANKS
·
18 Feb

Petros Pharmaceuticals Announces Pricing of $9.6 Million Public Offering of Common Stock and Warrants

ACCESS Newswire
·
18 Feb

‘Puzzling’: Malaysia’s new rules for Sarawak’s oil and gas sector set to trigger fresh political tensions

CNA
·
10 Feb

Malaysia’s Petronas to cut jobs to ensure survival: reports

businesstimes
·
07 Feb

Petros Pharmaceuticals files to sell units, no amount given

TIPRANKS
·
25 Jan

Malaysia PM says Petronas retains national role after Sarawak gas deal

CNA
·
15 Jan

Petros announces ‘conducive position’ with newly approved FDA OTC final rules

TIPRANKS
·
07 Jan

Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules

ACCESSWIRE
·
07 Jan

Maxim Group Keeps Their Buy Rating on Petros Pharmaceuticals (PTPI)

TIPRANKS
·
21 Dec 2024

Petros Pharmaceuticals Featured in “New Era of Healthcare, AI, Data and Consumer Empowerment”

ACCESSWIRE
·
19 Dec 2024

Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

Benzinga
·
18 Dec 2024

Petros to shift focus to development of tech as Rx-to-OTC switch solution

TIPRANKS
·
17 Dec 2024

Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annually

ACCESSWIRE
·
17 Dec 2024